Most Profitable Pharmaceuticals Companies

Net Income
Net IncomeEfficiencyMarket RiskExp Return
1TAK Takeda Pharmaceutical Co
144.07 B
(0.13)
 0.88 
(0.12)
2NVO Novo Nordisk AS
83.68 B
(0.21)
 1.81 
(0.37)
3RDY Dr Reddys Laboratories
55.68 B
(0.17)
 1.31 
(0.22)
4JNJ Johnson Johnson
13.33 B
(0.10)
 0.78 
(0.08)
5NVS Novartis AG ADR
8.57 B
(0.21)
 0.97 
(0.20)
6BMY Bristol Myers Squibb
8.04 B
 0.16 
 1.99 
 0.33 
7SNY Sanofi ADR
5.4 B
(0.19)
 1.20 
(0.23)
8LLY Eli Lilly and
5.24 B
(0.19)
 1.80 
(0.35)
9GSK GlaxoSmithKline PLC ADR
4.93 B
(0.22)
 1.53 
(0.33)
10ZTS Zoetis Inc
2.34 B
(0.02)
 1.26 
(0.03)
11PFE Pfizer Inc
2.13 B
(0.11)
 1.39 
(0.15)
12RPRX Royalty Pharma Plc
1.13 B
(0.09)
 0.99 
(0.09)
13OGN Organon Co
1.02 B
(0.32)
 1.85 
(0.59)
14JAZZ Jazz Pharmaceuticals PLC
414.83 M
 0.09 
 2.04 
 0.18 
15MRK Merck Company
365 M
(0.20)
 1.15 
(0.23)
16PBH Prestige Brand Holdings
209.34 M
 0.21 
 1.22 
 0.25 
17INVA Innoviva
179.72 M
 0.02 
 1.12 
 0.02 
18HRMY Harmony Biosciences Holdings
128.85 M
 0.00 
 3.85 
(0.02)
19VTRS Viatris
54.7 M
 0.10 
 2.26 
 0.22 
20PCRX Pacira BioSciences,
41.95 M
 0.14 
 2.36 
 0.32 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors. Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.